In prostate cancer, watchful waiting may not be best for African Americans
the ONA take:
According to a new study, African American men may not benefit from watchful waiting after being diagnosed with low-grade prostate cancer. In the study, researchers analyzed "pathologic," rather than "biopsy," Gleason scores of men with low-grade prostate cancer that had all or part of their prostate removed via surgery.
They found that African American men were more likely to experience disease progression and poorer outcomes compared with Caucasian men. Specifically, 79% of African American men had disease control at 7 years, while 90% of Caucasian men had 7-year disease control, a difference of 11%.
Kosj Yamoah, MD, PhD, Chief Resident of the Department of Radiation Oncology at Thomas Jefferson University in Philadelphia, Pennsylvania, says their study suggests that African American men with low-grade prostate cancer should be treated more aggressively than Caucasian men. When a patient is diagnosed with low-grade disease, many clinicians and patients opt for watchful waiting rather than treatment; however, this option may not be best for African Americans, whose cancer is more likely to develop aggressively sooner than Caucasian men.
Dr. Yamoah and his team are also researching how to identify which African American men with low-grade disease have an increased risk for disease progression.
May not benefit from watchful waiting after being diagnosed with low-grade prostate cancer.
There is an active controversy among oncologists about when to treat prostate cancer patients, with some suggesting that the word "cancer" be removed from the description of low grade disease, in order to prevent over-treatment. However a new study shows that these guidelines may not be appropriate for everyone, especially African American men.
"We know that African American men have more aggressive prostate cancer than Caucasian men," says Kosj Yamoah M.D., Ph.D., Chief Resident, Department of Radiation Oncology at Thomas Jefferson University. "Our study shows that African American men who are diagnosed with a low-grade cancer at first - the cancers that are sometimes watched rather than treated - are more likely to develop aggressive disease sooner than Caucasian men."
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
- Zinc Sulfate Improves Chemotherapy-Induced Mucositis Outcomes in Leukemia
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|